N
Ningbo Bohui Chemical Technology Co Ltd
SZSE:300839
Ningbo Bohui Chemical Technology Co Ltd
SZSE:300839
Price:
9.15
CNY
-0.11%
Market Closed
Market Cap:
2.2B
CNY
Balance Sheet
Balance Sheet Decomposition
Ningbo Bohui Chemical Technology Co Ltd
Ningbo Bohui Chemical Technology Co Ltd
| Current Assets | 1.1B |
| Cash & Short-Term Investments | 509.6m |
| Receivables | 145.4m |
| Other Current Assets | 403.8m |
| Non-Current Assets | 1.1B |
| Long-Term Investments | 16.8m |
| PP&E | 769.9m |
| Intangibles | 288.8m |
| Other Non-Current Assets | 847.7k |
Balance Sheet
Ningbo Bohui Chemical Technology Co Ltd
Ningbo Bohui Chemical Technology Co Ltd
Currency: CNY
Millions
Annual
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2
|
84
|
57
|
21
|
46
|
45
|
73
|
213
|
470
|
434
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
73
|
213
|
470
|
434
|
|
| Cash Equivalents |
2
|
84
|
57
|
21
|
46
|
45
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
30
|
70
|
0
|
30
|
50
|
205
|
1
|
76
|
|
| Total Receivables |
46
|
100
|
103
|
110
|
164
|
311
|
341
|
319
|
157
|
145
|
|
| Accounts Receivables |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Other Receivables |
46
|
100
|
103
|
109
|
164
|
310
|
340
|
318
|
156
|
0
|
|
| Inventory |
24
|
22
|
50
|
77
|
101
|
154
|
213
|
393
|
345
|
325
|
|
| Other Current Assets |
1
|
21
|
16
|
15
|
32
|
18
|
34
|
81
|
110
|
79
|
|
| Total Current Assets |
73
|
228
|
256
|
293
|
344
|
558
|
711
|
1 211
|
1 083
|
1 059
|
|
| PP&E Net |
38
|
65
|
31
|
196
|
666
|
806
|
872
|
944
|
920
|
770
|
|
| PP&E Gross |
38
|
65
|
31
|
196
|
666
|
806
|
872
|
944
|
920
|
770
|
|
| Accumulated Depreciation |
24
|
31
|
37
|
41
|
46
|
49
|
97
|
192
|
281
|
475
|
|
| Intangible Assets |
6
|
27
|
86
|
87
|
85
|
87
|
85
|
83
|
80
|
289
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
10
|
10
|
12
|
13
|
14
|
17
|
|
| Other Long-Term Assets |
1
|
3
|
2
|
2
|
2
|
10
|
31
|
19
|
14
|
1
|
|
| Total Assets |
117
N/A
|
322
+175%
|
375
+17%
|
578
+54%
|
1 106
+92%
|
1 471
+33%
|
1 711
+16%
|
2 270
+33%
|
2 111
-7%
|
2 135
+1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
4
|
11
|
11
|
16
|
130
|
92
|
69
|
94
|
141
|
49
|
|
| Accrued Liabilities |
4
|
6
|
8
|
8
|
11
|
16
|
21
|
35
|
140
|
154
|
|
| Short-Term Debt |
5
|
56
|
18
|
84
|
117
|
265
|
470
|
600
|
487
|
536
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
66
|
0
|
96
|
34
|
82
|
227
|
|
| Other Current Liabilities |
11
|
14
|
30
|
5
|
22
|
20
|
39
|
44
|
51
|
35
|
|
| Total Current Liabilities |
23
|
86
|
67
|
113
|
347
|
393
|
695
|
807
|
901
|
1 000
|
|
| Long-Term Debt |
0
|
0
|
0
|
91
|
334
|
225
|
141
|
440
|
454
|
638
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
75
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
19
|
22
|
20
|
23
|
20
|
|
| Total Liabilities |
23
N/A
|
86
+268%
|
67
-22%
|
204
+203%
|
680
+233%
|
637
-6%
|
857
+35%
|
1 269
+48%
|
1 382
+9%
|
1 733
+25%
|
|
| Equity | |||||||||||
| Common Stock |
36
|
78
|
78
|
78
|
78
|
104
|
135
|
176
|
245
|
245
|
|
| Retained Earnings |
55
|
81
|
153
|
219
|
271
|
298
|
318
|
459
|
235
|
72
|
|
| Additional Paid In Capital |
3
|
77
|
77
|
77
|
77
|
433
|
401
|
361
|
291
|
291
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
60
|
80
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
18
|
18
|
|
| Total Equity |
93
N/A
|
236
+152%
|
308
+30%
|
374
+21%
|
426
+14%
|
835
+96%
|
854
+2%
|
1 002
+17%
|
729
-27%
|
402
-45%
|
|
| Total Liabilities & Equity |
117
N/A
|
322
+175%
|
375
+17%
|
578
+54%
|
1 106
+92%
|
1 471
+33%
|
1 711
+16%
|
2 270
+33%
|
2 111
-7%
|
2 135
+1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
36
|
78
|
78
|
78
|
78
|
104
|
246
|
245
|
241
|
239
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
